189
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension

, , , , &
Pages 1079-1088 | Published online: 21 Jun 2018

Figures & data

Table 1 Final health states

Table 2 Example health state

Table 3 Sociodemographic and EQ-5D-5L results

Figure 1 Mean TTO utility scores for each PAH health state.

Notes: *p-value vs oral health state; p<0.001; mixed model F = 92.4, p<0.001.
Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; TTO, time trade-off.
Figure 1 Mean TTO utility scores for each PAH health state.

Figure 2 Mean VAS utility scores for each PAH health state.

Notes: *p-value vs oral health state; p<0.001; mixed model F = 326.5, p<0.001.
Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; VAS, visual analog scale.
Figure 2 Mean VAS utility scores for each PAH health state.

Figure 3 Mean disutilities of TTO utility scores for each non-oral vs oral PAH health state.

Notes: *p-value vs oral health state; p<0.001.
Abbreviations: PAH, pulmonary arterial hypertension; SD, standard deviation; TTO, time trade-off.
Figure 3 Mean disutilities of TTO utility scores for each non-oral vs oral PAH health state.

Table 4 Results from the univariable and multivariable mixed effects regression models of TTO utility scores, with p-values significant at p<0.05 indicated in bold